Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: Role of NAD(P)H oxidase

European Heart Journal

Volumn 36, Issue 43, 2015, Pages 3023-3030

  Virdis, Agostino ^a   Duranti, Emiliano ^a   Colucci, Rocchina ^a   Ippolito, Chiara ^a   Tirotta, Erika ^a   Lorenzini, Gianni ^a   Bernardini, Nunzia ^a   Blandizzi, Corrado ^a   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Ghrelin Nitric oxide Microcirculation Oxidative stress Hypertension

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; GHRELIN; GLYCOPROTEIN GP 91; INTERLEUKIN 6; LIPID PEROXIDE; MALONALDEHYDE; N(G) METHYLARGININE; NITRIC OXIDE; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; ANTIOXIDANT; ENZYME INHIBITOR; NEUTROPHIL CYTOSOLIC FACTOR 1; REACTIVE OXYGEN METABOLITE; VASODILATOR AGENT;

ADULT; ANTIOXIDANT ACTIVITY; ARTERY; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HUMAN; INFLAMMATION; MALE; MICROCIRCULATION; OXIDATIVE STRESS; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKIN BIOPSY; WESTERN BLOTTING; ANALYSIS OF VARIANCE; BIOSYNTHESIS; CASE CONTROL STUDY; ENZYMOLOGY; FOREARM; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANTIOXIDANTS; ASCORBIC ACID; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; FOREARM; GHRELIN; HUMANS; HYPERTENSION; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NADPH OXIDASE; NITRIC OXIDE; OMEGA-N-METHYLARGININE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASODILATOR AGENTS;

EID: 84983190418     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv365     Document Type: Article

References (29)

1. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Luscher TF, Shechter M, Taddei S, Vita JA, Lerman A. The assessment of endothelial function: from research into clinical practice. Circulation 2012;126:753-767.
2. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysi-ology to practice. J Am Coll Cardiol 2009;54:2129-2138.
3. Virdis A, Ghiadoni L, Versari D, Giannarelli C, Salvetti A, Taddei S. Endothelial function assessment in complicated hypertension. Curr Pharm Des 2008;14:1761-1770.
4. Brandes RP. Endothelial dysfunction and hypertension. Hypertension 2014;64: 924-928.
5. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111: 363-368.
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402: 656-660.
7. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198.
8. Kleinz MJ, Maguire JJ, Skepper JN, Davenport AP. Functional and immunocyto-chemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 2006;69:227-235.
9. Kawczynska-Drozdz A, Olszanecki R, Jawien J, Brzozowski T, Pawlik WW, Korbut R, Guzik TJ. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens 2006;19:764-767.
10. El Eter E, Al Tuwaijiri A, Hagar H, Arafa M. In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol 2007; 22:1791-1799.
11. Obay BD, Tasdemir E, Tumer C, Bilgin H, Atmaca M. Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Pep-tides 2008;29:448-455.
12. Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D, Cardillo C. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005;112:2986-2992.
13. Tesauro M, Schinzari F, Rovella V, Di Daniele N, Lauro D, Mores N, Veneziani A, Cardillo C. Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension 2009;54:995-1000.
14. Natali A, Taddei S, Quinones Galvan A, Camastra S, Baldi S, Frascerra S, Virdis A, Sudano I, Salvetti A, Ferrannini E. Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. Circulation 1997;96: 849-855.
15. Virdis A, Ghiadoni L, Qasem AA, Lorenzini G, Duranti E, Cartoni G, Bruno RM, Bernini G, Taddei S. Effect of aliskiren treatment on endothelium-dependent vaso-dilation and aortic stiffness in essential hypertensive patients. Eur Heart J 2012;33: 1530-1538.
16. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Ferrannini E, Salvetti A, Monzani F. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2006;91: 5076-5082.
17. Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 2001;38:1106-1115.
18. Virdis A, Colucci R, Fornai M, Blandizzi C, Duranti E, Pinto S, Bernardini N, Segnani C, Antonioli L, Taddei S, Salvetti A, Del Tacca M. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther 2005;312:945-953.
19. Virdis A, Bacca A, Colucci R, Duranti E, Fornai M, Materazzi G, Ippolito C, Bernardini N, Blandizzi C, Bernini G, Taddei S. Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension 2013;62:337-344.
20. Johnson JL, Park JW, Benna JE, Faust LP, Inanami O, Babior BM. Activation of p47(phox), a cytosolic subunit of the leukocyte nadph oxidase. Phosphorylation of ser-359 or ser-370 precedes phosphorylation at other sites and is required for activity. J Biol Chem 1998;273:35147-35152.
21. Virdis A, Santini F, Colucci R, Duranti E, Salvetti G, Rugani I, Segnani C, Anselmino M, Bernardini N, Blandizzi C, Salvetti A, Pinchera A, Taddei S. Vascular generation of tumor necrosis factor-alpha reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011;58:238-247.
22. Virdis A, Duranti E, Rossi C, Dell'Agnello U, Santini E, Anselmino M, Chiarugi M, Taddei S, Solini A. Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue. Eur Heart J 2015;36:784-794.
23. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C, Weintraub NL. Ghrelin inhibits proinflammatory responses and nuclear factor-kappa activation in human endothelial cells. Circulation 2004; 109:2221-2226.
24. Iantorno M, Chen H, Kim JA, Tesauro M, Lauro D, Cardillo C, Quon MJ. Ghrelin has novel vascular actions that mimic pi 3-kinase-dependent actions of insulin to stimulate production of no from endothelial cells. Am J Physiol Endocrinol Metab 2007;292: E756-E764.
25. Rabelink TJ, Luscher TF. Endothelial nitric oxide synthase: host defense enzyme of the endothelium? Arterioscler Thromb Vasc Biol 2006;26:267-271.
26. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003;52:2546-2553.
27. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357.
28. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004;89:1630-1635.
29. Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschop M, Pasquali R. Plasma ghrelin, obesity, and the polycystic ovary syndrome: Correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 2002;87:5625-5629.